MedTrace Logo

Research Into the Quality of the Dying Phase

NCT02822690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-04-19

No results posted yet for this study

Summary

The aim of this study is to get insight in the quality of life at the end of life and quality of dying for patients died at the hospital in the department Groningen (the Netherlands).

The primary endpoint is the quality of life at the end of life and the secondary endpoint is the quality of dying. Both according a numerical rating scale.

An explorative analysis will be done for differences for the hospitals in Groningen, effect of using the Liverpool care Pathway for the dying, effect of using consultation by the palliative consultation team, effect of using the Hospice@UMCG intervention, correlation with the quality of life at the end of life and quality of dying according to nurses and doctors.

Conditions

  • Cessation of Life

Interventions

OTHER

Hospice care at UMCG

introduction of hospice care facilities on the wards at the UMCG

Sponsors & Collaborators

  • Martini Hospital Groningen

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • An KL Reyners, MD/PhD · UMCG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02822690 on ClinicalTrials.gov